Back to Agendas
A Biopharmaceutical Company/Services Provider Partnership: Value to Both Companies and Progress to Date
Session Chair(s)
Stacie Yonkin
, Covance, United States
This session will focus on the rationale and benefits of establishing a sole source partnership between two companies that are leaders in the clinical development space and possess complementary areas of expertise and company culture.
Learning Objective : Describe the rationale behind the partnership between a biopharmaceutical company and a contract research organization (CRO); Discuss implementation of best practices in clinical development; Examine early successes and lessons learned; Explain the potential of this partnership model for other biopharmaceutical companies and CROs.
Speaker(s)
CRO Perspective
Stacie Yonkin
, Covance, United States
Pharma Perspective
Frances Grote, MBA
Senior Director, Clinical Operations Vendor Oversight, Biogen Inc., United States
Have an account?
Ways to register
Registration override should work.